 |
(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-29 00:00:00 |
| Sponsor | BeiGene USA, Inc.;2115 Linwood Avenue, 4th Floor;Fort Lee, New Jersey, 07024 |
